A Singapore study tracking 328 mother-child pairs has found two distinct pathways linking maternal mental health to child ...
The U.S. Food and Drug Administration (FDA)’s March 2026 update to its biosimilar Q&A guidance arrives at a critical inflection point for ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s ...
From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.
March 16, 2026) - Critical Minerals Americas Inc. (CMAI) today announced that Natural Resources Canada (NRCan) will undertake a comprehensive review of the Company's historical metallurgical and ...
Researchers have discovered that mutations in the FOXJ3 gene act as a "master switch" failure, disrupting how the brain builds its layers and leading to FCD, a primary cause of drug-resistant epilepsy ...
During the legislative session that ended last week at the state Capitol in Pierre, there were numerous bills introduced by ...
A study of 293 infants found that parents' perception of financial insufficiency — not objective poverty, but the feeling of ...
Understand the impact of IND delays on biotechnology companies and how they affect early-stage development and funding.
Researchers have long known that temperature can determine whether some reptiles develop as male or female, but this process ...
Cathy Burgess, Yifan Wang, Ph.D. Our FDA: Drug & Device Team explores the Food and Drug Administration’s updated draft guidance that eases biosimilar development by allowing greater use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results